Efficacy of Metformin and Diane-35 on PCOS Patients,a Randomized, Controlled, Prospective Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Polycystic Ovary SyndromeInsulin Resistance
Interventions
DRUG

Metformin

425mg bid for morning and evening after meals, one week after treatment, increase the dosage to 850 mg bid. If the patients have side effects such as nausea, diarrhea and other gastrointestinal symptoms, the dose would be reduced to 425mg bid for 1 week, and try the dosage to 425mg tid again, until the maximum tolerated dose.

DRUG

Ethinylestradiol and Cyproterone Acetate

from the first day of bleeding of the menstrual cycle, daily oral administration of one pill for 21 days consecutively, then stopped taking the pill for seven days, and on the eighth day to start taking the pill again.

Trial Locations (1)

400016

The First Affiliated Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors
lead

Chongqing Medical University

OTHER

NCT01573377 - Efficacy of Metformin and Diane-35 on PCOS Patients,a Randomized, Controlled, Prospective Clinical Trial | Biotech Hunter | Biotech Hunter